ANTI-NUCLEAR ANTIBODY TESTING MARKET ANALYSIS

Leading Companies

Global Anti-nuclear Antibody Testing market: Competitive landscape

Key players operating in the anti-nuclear antibody testing market include F. Hoffmann-La Roche Ltd., ERBA Diagnostics, Zeus Scientific, Inc., Alere Inc., Bio-Rad Laboratories, Inc., Becton Dickinson and Company, Antibodies, Inc., EUROIMMUN AG, Immuno Concepts, Inova Diagnostics, Thermo Fisher Scientific, Inc., and Trinity Biotech plc.

These key players focus on mergers, acquisitions, collaborations, product launches, R&D activities, and geographical expansion. For instance, in June 2018, Grifols, a European pharmaceutical and chemical manufacturer, received the U.S. Food and Drug Administration approval for its HELIOS Automated System for IFA, which is used for the diagnosis of autoimmune disorders such as Lupus, Scleroderma, and Antineutrophil Cytoplasmic Antibodies (ANCA)-associated vasculitis. HELIOS enables the laboratories to standardize and reduce time consumption of the diagnostic test, hence driving the growth of anti-nuclear antibody testing market.